Senseonics Holdings Inc (SENS) - Long-Term Debt to Capital Coefficient

Corporate emblem and logo of Senseonics Holdings Inc (SENS)

Senseonics Holdings (SENS) is fighting for user attention amid a fierce confrontation between tech giants and wearable gadget developers. This price chart, where the indicator equals 0.73, complements the analysis of the subcutaneous glucose sensor model, which generates steady revenue through the regular replacement of consumables. However, the business relies on a single core product, meaning financial stability depends on the success of global agreements with major players.

SENS Senseonics Holdings: Long-Term Debt to Equity in the range 07/04/2022 - 10/31/2026

Analytical breakdowns for Senseonics Holdings

- share price and consensus valuation forecast:
Price Senseonics|SENS - Analyst Consensus Forecast
- market capitalization indicators:
Market Value Senseonics Holdings, Inc.|SENS - Enterprise Value
- balance sheet net asset value indicators:
Net Asset Value per Share Senseonics|SENS - Company Book Value|Market Value to Book Value senseonics.com|SENS - Company Total Assets
- debt and solvency information:
Total Debt to Capital Senseonics Holdings|SENS - Long-Term Debt to Equity|Current Liabilities to Equity Senseonics Corp|SENS - Company Aggregate Debts|Debts to Book Value Senseonics Holdings, Inc.|SENS - Company Long-Term Liabilities|Company Short-Term Debts Senseonics|Intermediate Liquidity Ratio senseonics.com
- business earnings and investment ratios data:
SENS - Net Profit
Summary company analysis:SENS (Senseonics Holdings)
Core merchandise of Senseonics

This indicator measures the proportion of long-term debt obligations relative to equity, determining the business's financial resilience to systemic market shocks. Analyzing the long-term debt-to-equity ratio allows for an assessment of how effectively Senseonics Holdings (SENS) finances the development of its implantable glucose monitoring ecosystem while maintaining a balance between investment growth and the risk of excessive asset leverage.

Competing companies

DXCM (DexCom Inc) - Long-Term Loans to Capital Ratio|Long-Term Debt to Capital PEN|NOVT (Novanta Photonics) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital HAE (Haemonetics Corporation)|inspiresleep.com (INSP) - Long-Term Liabilities to Capital|PRCT - Long-Term Debt to Equity|Long-Term Debt to Capital Coefficient CNMD (CONMED Corp)|PLSE: Long-Term Debt to Capital|InMode MD (INMD) - Long-Term Debt to Capital|Long-Term Debt to Equity Picard Medical Inc|surmodics.com - Long-Term Liabilities to Equity|Long-Term Debt to Capital NPCE|TCMD - Long-Term Liabilities to Capital|SANUWAVE Health, Inc. - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Outset Medical Corp OM|ELMD: Long-Term Debt to Equity Ratio|lensar.com - Long-Term Loans to Capital Ratio|RCEL: Long-Term Debt to Capital|PROF - Ratio of Long-Term Indebtedness to Capital|BDMD (Baird Medical Investment Holdings) - Long-Term Debt to Capital|Long-Term Debt to Equity Ratio EDAP Medical (EDAP)|Long-Term Debt to Equity Ratio APYX (Apyx Medical)|ICCM (icecure-medical.com) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Equity Pulmonx LUNG|TELA - Long-Term Debt to Equity Ratio|CytoSorbents Corp. - Long-Term Debt to Capital|Long-Term Liabilities to Capital Sensus|ZYXI: Long-Term Debt to Capital|Long-Term Debt to Capital Ratio ECOR|RBOT (Vicarious Surgical Inc) - Long-Term Debt to Capital|Inspira Technologies Oxy B.H.N. Ltd (IINN) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Capital ICU|Long-Term Debt to Equity Ratio iridex.com IRIX|Long-Term Debt to Capital INBS (Intelligent Bio Solutions Inc.)|Long-Term Debt to Capital Beyond Air Inc XAIR|PFSA - Long-Term Debt to Equity|SSKN: Long-Term Debt to Equity|GCTK (GlucoTrack) - Long-Term Debt to Equity Ratio|NanoVibronix Inc. - Long-Term Debt to Capital Coefficient|VERO (Venus Concept Inc.) - Long-Term Debt to Capital|Long-Term Liabilities to Capital nuwellis.com NUWE|Long-Term Debt to Equity Aethlon Medical, Inc. (AEMD)|asensus.com (ASXC) - Long-Term Indebtedness to Equity|Avinger, Inc - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital BioSig Technologies Inc. BSGM|Cutera, Inc. - Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital knowlabs.co KNW|Inari Medical (NARI) - Long-Term Debt to Equity|Long-Term Liabilities to Equity NVRO (Nevro Corp)|Long-Term Debt to Equity ReShape Lifesciences, Inc.|Long-Term Debt to Equity Ratio Silk Road Medical Inc (SILK)